Boston Scientific Corporation
Overview
Boston Scientific Corporation is a global medical technology leader that develops, manufactures, and commercializes a wide range of medical devices used in interventional medical specialties. Their products are used in various fields, including interventional cardiology, electrophysiology, endoscopy, urology, and neuromodulation, among others. The company's portfolio of devices and therapies helps physicians diagnose and treat complex diseases and conditions.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| SetPoint Medical | Aug 2025 | Series C Extension | Co-investor |
| SetPoint Medical | Aug 2025 | Series D | Co-investor |
| 4C Medical | Mar 2025 | Series D | Lead |
| Nectero Medical | Apr 2024 | Series D | Co-investor |
| Nectero Therapeutics | Jan 2024 | Series D | Co-investor |
Key People
Exportconsulting S.A.
Principal CEO
Adam Trzpil
Business Support Partner With German
Bruno Souza
HR People Partner Latam
Cathy Gavin
People Partner III
Georgette Flowers
HR Bsuiness Partner
Laura Raymakers
Business Support Partner
Mette Andersson
Business Support Partner
Katie Routh
R D Director
Amanda Wallo
International Principal Product Manager, Deep Brain Stimulation
Austin McMinn
Principal Territory Manager
Brock Edwards
Group Marketing Manager, Principal Global Product Manager, Senior Global Product Manager
Dat Huynh
Principal Data Scientist
Eric R.
Principal Project Lead
Jessica Steppe
Principal Global Product Manager
Jin Zhou
Principal Data Scientist
Jody Kangas
Principal Data Architect
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
